Table 2 NADMs identified in PLWHA receiving antiretroviral therapy by cancer type (n = 145)
Cancer type | Number of cases (% of NADMs) | Incidence rate (per 100,000 person-years) |
|---|---|---|
Breast | 5 (3.4) | 100.03 |
Lung | 30 (20.7) | 104.97 |
Gastrointestinal | ||
 Liver | 8 (5.5) | 27.99 |
 Gastric | 2 (1.4) | 6.99 |
 Colon | 3 (2.1) | 10.50 |
 Rectum | 8 (5.5) | 27.99 |
 Anal | 29 (20.0) | 101.47 |
Genital | ||
 Vulva | 3 (2.1) | 60.02 |
 Testicle, scrotum | 3 (2.1) | 12.72 |
 Prostate | 9 (6.2) | 38.17 |
Urinary | ||
 Bladder | 2 (1.4) | 6.99 |
 Kidney | 8 (5.5) | 27.99 |
Skin | ||
 Melanoma | 2 (1.4) | 6.99 |
Other | ||
 Unknown primary | 5 (3.4) | 17.50 |
 Soft tissue | 2 (1.4) | 6.99 |
 Brain, spinal cord | 2 (1.4) | 6.99 |
 Hematologic | 5 (3.4) | 17.50 |
 Lymphatic system | 10 (6.9) | 34.99 |